missing translation for 'onlineSavingsMsg'
Learn More

Phospho-Tau (Thr231) Monoclonal Antibody (AT180), Invitrogen™

Mouse Monoclonal Antibody

Marke:  Invitrogen MN1040

Weitere Details : Netto-Gewicht : 0.68040kg

Artikelnummer. 11503010

  • 686.00 € / 100 Mikrogramm
Lager vorrätig
Sie sich ein, um den Lagerbestand zu sehen

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!


Beschreibung

Beschreibung

MN1040 recognizes PHF-Tau and tangles. Cross-reacts weakly with normal Tau. Does not cross react with recombinant unphosphorylated human Tau. The epitope of this antibody is the phosphorylated Thr231 residue (numbering according to human Tau40). MN1040 detects PHF-tau (Thr231) which has a predicted molecular weight of approximately 79 kDa. Purity is >95% as determined by SDS-PAGE.

Tau is a neuronal microtubule-associated protein found predominantly on axons. The function of Tau is to promote tubulin polymerization and stabilize microtubules. The C-terminus binds axonal microtubules while the N- terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton while the longer isoforms may preferentially play a role in its stabilization. In its hyper-phosphorylated form, Tau is the major component of paired helical filaments (PHF), the building block of neurofibrillary lesions in Alzheimer's diseases (AD) brain. Hyper-phosphorylation impairs the microtubule binding function of Tau, resulting in the destabilization of microtubules in AD brains, μgtimately leading to the degeneration of the affected neurons. Numerous serine/threonine kinases phosphorylate Tau, including GSK-3beta, protein kinase A (PKA), cyclin-dependent kinase 5 (cdk5) and casein kinase II. Hyper-phosphorylated Tau is found in neurofibrillary lesions in a range and other central nervous system disorders such as Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Spezifikation

Spezifikation

Phospho-Tau (Thr231)
Monoclonal
0.2 mg/mL
100 μg Antikörper aus serumfreiem Zellkulturüberstand aufgereinigt durch Protein A-Affinitätschromatographie; in PBS und ohne Konservierungs- und Trägermittel.
P10636, P19332
MAPT
Partially purified human PHF-Tau
100 μg
Primary
Human, Rat
Antibody
IgG1 κ
ELISA, Immunohistochemistry (Paraffin), Western Blot
AT180
Unconjugated
MAPT
AI413597; AW045860; DDPAC; FLJ31424; FTDP17; FTDP-17; G protein beta1/gamma2 subunit-interacting factor 1; map tau; Mapt; MAPTL; MGC138549; microtubule associated protein tau; microtubule-associated protein tau; microtubule-associated protein tau, isoform 4; microtubules; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; neurofibrillary tangles; Neuronal Marker; paired helical filament-tau; PHFtau; PHF-tau; PPND; PPP1R103; protein phosphatase 1, regulatory subunit 103; pTau; RNPTAU; Tau; Tau microtubule-associated protein; tau protein; Tau-4; Tau5; Unknown (protein for MGC:134287)
Mouse
purified
RUO
29477, 4137
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Sonderangebote

Sonderangebote